https://doi.org/10.1093/neuonc/noz150
H
Haley Gittleman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
29.1K
Citations
38
h-index
68
i10-index
Haley Gittleman is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Renal cell carcinoma treatment & Brain Metastases and Treatment. The author has an h-index of 38, co-authored 98 publications.
ORCID: 0000-0002-6976-8777Papers by this author
worksCBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 · Neuro-Oncology · 2,550 citations
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 · Neuro-Oncology · 2,161 citations
https://doi.org/10.1093/neuonc/noy131
An anatomic transcriptional atlas of human glioblastoma
2018 · Science · 674 citations
https://doi.org/10.1126/science.aaf2666
Racial disparities in melanoma survival
2016 · Journal of the American Academy of Dermatology · 192 citations
https://doi.org/10.1016/j.jaad.2016.06.006
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
2016 · Neuro-Oncology · 170 citations
https://doi.org/10.1093/neuonc/now208
Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States
2018 · Neuro-Oncology · 99 citations
https://doi.org/10.1093/neuonc/noy162
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat